Evidence map›Paper›PMID 32471374›Full record

ArticleBMC nephrology2020

Association of aortic valve calcification with carotid artery lesions and peripheral artery disease in patients with chronic kidney disease: a cross-sectional study.

Yui Arita, Masaru Nakayama, Yuta Matsukuma, Ryota Yoshitomi, Makiko Seki, Akiko Fukui, Susumu Tsuda, Yuri Sonoda, Rina Imazu, Kimika Arakawa and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMC nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Yui AritaDivision of Nephrology, Department of Internal Medicine, Yamaguchi Red Cross Hospital, 53-1 Yawatanobaba, Yamaguchi, 753-0092, Japan.
Masaru NakayamaDepartment of Internal Medicine, National Hospital Organization Kyushu Medical Center, Division of Nephrology and Clinical Research Institute, 1-8-1 Jigyohama, Chuo-ku, Fukuoka, 810-8563, Japan. nakayama51224@gmail.com.
Yuta MatsukumaDepartment of Internal Medicine, National Hospital Organization Kyushu Medical Center, Division of Nephrology and Clinical Research Institute, 1-8-1 Jigyohama, Chuo-ku, Fukuoka, 810-8563, Japan.
Ryota YoshitomiDepartment of Internal Medicine, National Hospital Organization Kyushu Medical Center, Division of Nephrology and Clinical Research Institute, 1-8-1 Jigyohama, Chuo-ku, Fukuoka, 810-8563, Japan.
Makiko SekiDepartment of Internal Medicine, National Hospital Organization Kyushu Medical Center, Division of Nephrology and Clinical Research Institute, 1-8-1 Jigyohama, Chuo-ku, Fukuoka, 810-8563, Japan.
Akiko FukuiDepartment of Internal Medicine, National Hospital Organization Kyushu Medical Center, Division of Nephrology and Clinical Research Institute, 1-8-1 Jigyohama, Chuo-ku, Fukuoka, 810-8563, Japan.
Susumu TsudaDepartment of Internal Medicine, National Hospital Organization Kyushu Medical Center, Division of Nephrology and Clinical Research Institute, 1-8-1 Jigyohama, Chuo-ku, Fukuoka, 810-8563, Japan.
Yuri SonodaDepartment of Internal Medicine, National Hospital Organization Kyushu Medical Center, Division of Nephrology and Clinical Research Institute, 1-8-1 Jigyohama, Chuo-ku, Fukuoka, 810-8563, Japan.
Rina ImazuDepartment of Internal Medicine, National Hospital Organization Kyushu Medical Center, Division of Hypertension and Clinical Research Institute, 1-8-1 Jigyohama, Chuo-ku, Fukuoka, 810-8563, Japan.
Kimika ArakawaDepartment of Internal Medicine, National Hospital Organization Kyushu Medical Center, Division of Hypertension and Clinical Research Institute, 1-8-1 Jigyohama, Chuo-ku, Fukuoka, 810-8563, Japan.
Mitsuhiro TominagaDepartment of Internal Medicine, National Hospital Organization Kyushu Medical Center, Division of Hypertension and Clinical Research Institute, 1-8-1 Jigyohama, Chuo-ku, Fukuoka, 810-8563, Japan.
Toshiaki NakanoDepartment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Kazuhiko TsuruyaDepartment of Nephrology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.
Takanari KitazonoDepartment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
National Kyushu Medical Center · JPKyushu University · JPNara Medical University · JPYamaguchi Red Cross Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with chronic kidney disease (CKD) reportedly have a high prevalence of aortic valve calcification (AVC). In population-based studies, AVC is considered a manifestation of systemic atherosclerosis. The association of AVC with atherosclerotic lesions has not been fully investigated in predialysis patients. The present study was performed to determine whether carotid artery lesions and peripheral artery disease (PAD) are associated with AVC in patients with CKD not on dialysis.

methodsIn total, 749 patients were included in this cross-sectional study. AVC was evaluated using echocardiography. Carotid artery lesions including carotid artery plaque (CAP) and PAD were simultaneously examined in each patient. A logistic regression analysis was applied to determine the factors associated with AVC.

resultsAVC, CAP, and PAD were found in 201, 583, and 123 patients, respectively. In the multivariable analyses adjusted for covariates including the estimated glomerular filtration rate and makers of mineral metabolism (serum calcium, serum phosphorus, parathyroid hormone, 1,25-dihydroxyvitamin D, and fibroblast growth factor 23), AVC was significantly associated with the presence of CAP [odds ratio (OR), 3.37; 95% confidence interval (CI), 1.43-7.95], the presence of PAD (OR, 1.76; 95% CI, 1.10-2.81), the CAP score (per 1.0-point increase) (OR, 1.06; 95% CI, 1.02-1.11), and the ankle-brachial blood pressure index (per 0.1-point increase) (OR, 0.83; 95% CI, 0.72-0.95).

conclusionsAVC was associated with atherosclerotic lesions independent of kidney function and mineral metabolism. We consider that this association between AVC and atherosclerosis might reflect the burden of shared atherosclerotic risk factors.

Indexed as

AdultAgedAged, 80 and overAnkle Brachial IndexAortic ValveAortic Valve StenosisCalcinosisCalciumCarotid Artery DiseasesCross-Sectional StudiesEchocardiographyFemaleFibroblast Growth Factor-23Fibroblast Growth FactorsHumansLansoprazole1,25-dihydroxyvitamin DCalciumFibroblast Growth Factor-23Fibroblast Growth FactorsLansoprazoleParathyroid HormonePhosphorusVitamin DAortic valve calcificationAtherosclerosisCarotid artery plaqueChronic kidney diseasePeripheral artery disease

Identifiers

PMID32471374
PMCPMC7260754
OpenAlexW3028674521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.